Stock exchange news | Navamedic

Read the latest news directly from the market.

Navamedic ASA: Q1 2022 financial results

Oslo, 10 May 2022 - Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products Read more

Navamedic ASA acquires Impolin AB and bolsters its product portfolio

The proposed acquisition reinforces Navamedic’s position in the market for obesity treatment The acquired portfolio enables Navamedic to support patients Read more

Navamedic: Annual report 2021

Oslo, 29 April 2022 - Navamedic ASA (OSE: NAVA) publishes its annual report for 2021. The report is attached and Read more

Navamedic ASA: Q4 2021 financial results

“The fourth quarter of 2021 was strong for Navamedic, resulting in a full year growth of 33%, compared to our Read more

Navamedic ASA launches SmectaGO® – an innovative on-the-go product for treatment of diarrhea

“Diarrhea and other gastro conditions are very common, but in the Nordics, we know from research that only 20 percent Read more

Navamedic ASA: Invitation to 2021 Fourth quarter presentation

Navamedic ASA invites you to a presentation of the 2021 fourth quarter results on Thursday, February 17th at 08.45 CET. Read more

Navamedic ASA: Trading Update

Reference is made to Navamedic’s communicated target of 20% annual growth for 2021. As the company’s preliminary financial results for Read more

Navamedic ASA has entered into a market making agreement with Norne Securities AS

Oslo, 11. November 2021 – Navamedic ASA (OSE: NAVA) today announces it has entered into a market making agreement with Read more

Subscribe to stock exhange news